Invention Grant
- Patent Title: Peptides effective in the treatment of conditions requiring the removal or destruction of cells
- Patent Title (中): 有效治疗需要去除或破坏细胞的条件的肽
-
Application No.: US14091168Application Date: 2013-11-26
-
Publication No.: US09243035B2Publication Date: 2016-01-26
- Inventor: Paul Averback , Jack Gemmell
- Applicant: NYMOX CORPORATION
- Applicant Address: CA St. Laurent, Quebec
- Assignee: NYMOX CORPORATION
- Current Assignee: NYMOX CORPORATION
- Current Assignee Address: CA St. Laurent, Quebec
- Agency: Pillsbury Winthrop Shaw Pittman, LLP
- Main IPC: A61K38/04
- IPC: A61K38/04 ; A61K38/16 ; C07K7/00 ; C07K9/00 ; C07K14/00 ; C07K7/08 ; C07K7/06 ; A61K38/00
Abstract:
The embodiments are directed to peptides, compositions, and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides.
Public/Granted literature
- US20150148303A1 PEPTIDES EFFECTIFE IN THE TREATMENT OF CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS Public/Granted day:2015-05-28
Information query
IPC分类:
